Other
SODIUM ACETATE
Injection, USP
40 mEq (2 mEq/mL)
FOR ADDITIVE USE ONLY AFTER DILUTION
IN INTRAVENOUS FLUIDS.
Glass Fliptop Vial
Rx only
Sodium Acetate Injection, Solution, Concentrate
FDA Label NDC 71357-002
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Milla Pharmaceuticals Inc. for the product Sodium Acetate (NDC 71357-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Principal Display Panel
Sodium Acetate Injection, USP 40 mEq/20 mL NDC 71357-002-10 Carton Label
Image Description (Sodium Acetate 40meq 20ml Carton Label)
Sodium Acetate Injection, USP 40 mEq/20 mL NDC 71357-002-01 vial Label
Image Description (Sodium Acetate 40meq 20ml Vial Label)
* Please review the disclaimer below.
